The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating obesity as a chronic illness. In a press release, the WHO said this guidance aimed to help reduce the "skyrocketing health costs" associated with obesity, which are projected to have a global economic cost of...

See Full Page